Global Cold Treatment Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030
1 Market Overview
- 1.1 Product Overview and Scope of Cold Treatment Drug
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Cold Treatment Drug by Type
- 1.3.1 Overview: Global Cold Treatment Drug Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Cold Treatment Drug Consumption Value Market Share by Type in 2023
- 1.3.3 Cough Medicine
- 1.3.4 Respiratory Infections
- 1.3.5 Others
- 1.4 Global Cold Treatment Drug Market by Application
- 1.4.1 Overview: Global Cold Treatment Drug Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Hospital Pharmacy
- 1.4.3 Retail Pharmacy
- 1.4.4 Online Pharmacy
- 1.5 Global Cold Treatment Drug Market Size & Forecast
- 1.6 Global Cold Treatment Drug Market Size and Forecast by Region
- 1.6.1 Global Cold Treatment Drug Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Cold Treatment Drug Market Size by Region, (2019-2030)
- 1.6.3 North America Cold Treatment Drug Market Size and Prospect (2019-2030)
- 1.6.4 Europe Cold Treatment Drug Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Cold Treatment Drug Market Size and Prospect (2019-2030)
- 1.6.6 South America Cold Treatment Drug Market Size and Prospect (2019-2030)
- 1.6.7 Middle East and Africa Cold Treatment Drug Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 Pfizer
- 2.1.1 Pfizer Details
- 2.1.2 Pfizer Major Business
- 2.1.3 Pfizer Cold Treatment Drug Product and Solutions
- 2.1.4 Pfizer Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Pfizer Recent Developments and Future Plans
- 2.2 Johnson & Johnson
- 2.2.1 Johnson & Johnson Details
- 2.2.2 Johnson & Johnson Major Business
- 2.2.3 Johnson & Johnson Cold Treatment Drug Product and Solutions
- 2.2.4 Johnson & Johnson Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Johnson & Johnson Recent Developments and Future Plans
- 2.3 VICKS
- 2.3.1 VICKS Details
- 2.3.2 VICKS Major Business
- 2.3.3 VICKS Cold Treatment Drug Product and Solutions
- 2.3.4 VICKS Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 VICKS Recent Developments and Future Plans
- 2.4 TEVA
- 2.4.1 TEVA Details
- 2.4.2 TEVA Major Business
- 2.4.3 TEVA Cold Treatment Drug Product and Solutions
- 2.4.4 TEVA Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 TEVA Recent Developments and Future Plans
- 2.5 Bayer
- 2.5.1 Bayer Details
- 2.5.2 Bayer Major Business
- 2.5.3 Bayer Cold Treatment Drug Product and Solutions
- 2.5.4 Bayer Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Bayer Recent Developments and Future Plans
- 2.6 GSK
- 2.6.1 GSK Details
- 2.6.2 GSK Major Business
- 2.6.3 GSK Cold Treatment Drug Product and Solutions
- 2.6.4 GSK Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 GSK Recent Developments and Future Plans
- 2.7 Novartis
- 2.7.1 Novartis Details
- 2.7.2 Novartis Major Business
- 2.7.3 Novartis Cold Treatment Drug Product and Solutions
- 2.7.4 Novartis Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Novartis Recent Developments and Future Plans
- 2.8 Centrient Pharma
- 2.8.1 Centrient Pharma Details
- 2.8.2 Centrient Pharma Major Business
- 2.8.3 Centrient Pharma Cold Treatment Drug Product and Solutions
- 2.8.4 Centrient Pharma Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 Centrient Pharma Recent Developments and Future Plans
- 2.9 Mylan
- 2.9.1 Mylan Details
- 2.9.2 Mylan Major Business
- 2.9.3 Mylan Cold Treatment Drug Product and Solutions
- 2.9.4 Mylan Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 Mylan Recent Developments and Future Plans
- 2.10 Cipla
- 2.10.1 Cipla Details
- 2.10.2 Cipla Major Business
- 2.10.3 Cipla Cold Treatment Drug Product and Solutions
- 2.10.4 Cipla Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.10.5 Cipla Recent Developments and Future Plans
- 2.11 NCPC
- 2.11.1 NCPC Details
- 2.11.2 NCPC Major Business
- 2.11.3 NCPC Cold Treatment Drug Product and Solutions
- 2.11.4 NCPC Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.11.5 NCPC Recent Developments and Future Plans
- 2.12 United Laboratories
- 2.12.1 United Laboratories Details
- 2.12.2 United Laboratories Major Business
- 2.12.3 United Laboratories Cold Treatment Drug Product and Solutions
- 2.12.4 United Laboratories Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.12.5 United Laboratories Recent Developments and Future Plans
- 2.13 Sun Pharma
- 2.13.1 Sun Pharma Details
- 2.13.2 Sun Pharma Major Business
- 2.13.3 Sun Pharma Cold Treatment Drug Product and Solutions
- 2.13.4 Sun Pharma Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.13.5 Sun Pharma Recent Developments and Future Plans
- 2.14 CSPC
- 2.14.1 CSPC Details
- 2.14.2 CSPC Major Business
- 2.14.3 CSPC Cold Treatment Drug Product and Solutions
- 2.14.4 CSPC Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.14.5 CSPC Recent Developments and Future Plans
- 2.15 LKPC
- 2.15.1 LKPC Details
- 2.15.2 LKPC Major Business
- 2.15.3 LKPC Cold Treatment Drug Product and Solutions
- 2.15.4 LKPC Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.15.5 LKPC Recent Developments and Future Plans
- 2.16 Hikma
- 2.16.1 Hikma Details
- 2.16.2 Hikma Major Business
- 2.16.3 Hikma Cold Treatment Drug Product and Solutions
- 2.16.4 Hikma Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.16.5 Hikma Recent Developments and Future Plans
- 2.17 Dr. Reddy
- 2.17.1 Dr. Reddy Details
- 2.17.2 Dr. Reddy Major Business
- 2.17.3 Dr. Reddy Cold Treatment Drug Product and Solutions
- 2.17.4 Dr. Reddy Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.17.5 Dr. Reddy Recent Developments and Future Plans
- 2.18 HPGC
- 2.18.1 HPGC Details
- 2.18.2 HPGC Major Business
- 2.18.3 HPGC Cold Treatment Drug Product and Solutions
- 2.18.4 HPGC Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.18.5 HPGC Recent Developments and Future Plans
- 2.19 Aurubindo
- 2.19.1 Aurubindo Details
- 2.19.2 Aurubindo Major Business
- 2.19.3 Aurubindo Cold Treatment Drug Product and Solutions
- 2.19.4 Aurubindo Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.19.5 Aurubindo Recent Developments and Future Plans
- 2.20 Meiji Holdings
- 2.20.1 Meiji Holdings Details
- 2.20.2 Meiji Holdings Major Business
- 2.20.3 Meiji Holdings Cold Treatment Drug Product and Solutions
- 2.20.4 Meiji Holdings Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.20.5 Meiji Holdings Recent Developments and Future Plans
- 2.21 Sudafed
- 2.21.1 Sudafed Details
- 2.21.2 Sudafed Major Business
- 2.21.3 Sudafed Cold Treatment Drug Product and Solutions
- 2.21.4 Sudafed Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.21.5 Sudafed Recent Developments and Future Plans
- 2.22 Merck
- 2.22.1 Merck Details
- 2.22.2 Merck Major Business
- 2.22.3 Merck Cold Treatment Drug Product and Solutions
- 2.22.4 Merck Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.22.5 Merck Recent Developments and Future Plans
- 2.23 Reckitt Benckiser
- 2.23.1 Reckitt Benckiser Details
- 2.23.2 Reckitt Benckiser Major Business
- 2.23.3 Reckitt Benckiser Cold Treatment Drug Product and Solutions
- 2.23.4 Reckitt Benckiser Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.23.5 Reckitt Benckiser Recent Developments and Future Plans
- 2.24 TYLENOL
- 2.24.1 TYLENOL Details
- 2.24.2 TYLENOL Major Business
- 2.24.3 TYLENOL Cold Treatment Drug Product and Solutions
- 2.24.4 TYLENOL Cold Treatment Drug Revenue, Gross Margin and Market Share (2019-2024)
- 2.24.5 TYLENOL Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Cold Treatment Drug Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Cold Treatment Drug by Company Revenue
- 3.2.2 Top 3 Cold Treatment Drug Players Market Share in 2023
- 3.2.3 Top 6 Cold Treatment Drug Players Market Share in 2023
- 3.3 Cold Treatment Drug Market: Overall Company Footprint Analysis
- 3.3.1 Cold Treatment Drug Market: Region Footprint
- 3.3.2 Cold Treatment Drug Market: Company Product Type Footprint
- 3.3.3 Cold Treatment Drug Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Cold Treatment Drug Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Cold Treatment Drug Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Cold Treatment Drug Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Cold Treatment Drug Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Cold Treatment Drug Consumption Value by Type (2019-2030)
- 6.2 North America Cold Treatment Drug Consumption Value by Application (2019-2030)
- 6.3 North America Cold Treatment Drug Market Size by Country
- 6.3.1 North America Cold Treatment Drug Consumption Value by Country (2019-2030)
- 6.3.2 United States Cold Treatment Drug Market Size and Forecast (2019-2030)
- 6.3.3 Canada Cold Treatment Drug Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Cold Treatment Drug Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Cold Treatment Drug Consumption Value by Type (2019-2030)
- 7.2 Europe Cold Treatment Drug Consumption Value by Application (2019-2030)
- 7.3 Europe Cold Treatment Drug Market Size by Country
- 7.3.1 Europe Cold Treatment Drug Consumption Value by Country (2019-2030)
- 7.3.2 Germany Cold Treatment Drug Market Size and Forecast (2019-2030)
- 7.3.3 France Cold Treatment Drug Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Cold Treatment Drug Market Size and Forecast (2019-2030)
- 7.3.5 Russia Cold Treatment Drug Market Size and Forecast (2019-2030)
- 7.3.6 Italy Cold Treatment Drug Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Cold Treatment Drug Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Cold Treatment Drug Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Cold Treatment Drug Market Size by Region
- 8.3.1 Asia-Pacific Cold Treatment Drug Consumption Value by Region (2019-2030)
- 8.3.2 China Cold Treatment Drug Market Size and Forecast (2019-2030)
- 8.3.3 Japan Cold Treatment Drug Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Cold Treatment Drug Market Size and Forecast (2019-2030)
- 8.3.5 India Cold Treatment Drug Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Cold Treatment Drug Market Size and Forecast (2019-2030)
- 8.3.7 Australia Cold Treatment Drug Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Cold Treatment Drug Consumption Value by Type (2019-2030)
- 9.2 South America Cold Treatment Drug Consumption Value by Application (2019-2030)
- 9.3 South America Cold Treatment Drug Market Size by Country
- 9.3.1 South America Cold Treatment Drug Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Cold Treatment Drug Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Cold Treatment Drug Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Cold Treatment Drug Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Cold Treatment Drug Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Cold Treatment Drug Market Size by Country
- 10.3.1 Middle East & Africa Cold Treatment Drug Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Cold Treatment Drug Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Cold Treatment Drug Market Size and Forecast (2019-2030)
- 10.3.4 UAE Cold Treatment Drug Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Cold Treatment Drug Market Drivers
- 11.2 Cold Treatment Drug Market Restraints
- 11.3 Cold Treatment Drug Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Cold Treatment Drug Industry Chain
- 12.2 Cold Treatment Drug Upstream Analysis
- 12.3 Cold Treatment Drug Midstream Analysis
- 12.4 Cold Treatment Drug Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Cold Treatment Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
This report focus on OTC drugs and wellness drugs to treat cold symptoms and respiratory infections.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Cold Treatment Drug industry chain, the market status of Hospital Pharmacy (Cough Medicine, Respiratory Infections), Retail Pharmacy (Cough Medicine, Respiratory Infections), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cold Treatment Drug.
Regionally, the report analyzes the Cold Treatment Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cold Treatment Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cold Treatment Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cold Treatment Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Cough Medicine, Respiratory Infections).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cold Treatment Drug market.
Regional Analysis: The report involves examining the Cold Treatment Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cold Treatment Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cold Treatment Drug:
Company Analysis: Report covers individual Cold Treatment Drug players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cold Treatment Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacy, Retail Pharmacy).
Technology Analysis: Report covers specific technologies relevant to Cold Treatment Drug. It assesses the current state, advancements, and potential future developments in Cold Treatment Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cold Treatment Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cold Treatment Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Cough Medicine
Respiratory Infections
Others
Market segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Market segment by players, this report covers
Pfizer
Johnson & Johnson
VICKS
TEVA
Bayer
GSK
Novartis
Centrient Pharma
Mylan
Cipla
NCPC
United Laboratories
Sun Pharma
CSPC
LKPC
Hikma
Dr. Reddy
HPGC
Aurubindo
Meiji Holdings
Sudafed
Merck
Reckitt Benckiser
TYLENOL
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cold Treatment Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cold Treatment Drug, with revenue, gross margin and global market share of Cold Treatment Drug from 2019 to 2024.
Chapter 3, the Cold Treatment Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cold Treatment Drug market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cold Treatment Drug.
Chapter 13, to describe Cold Treatment Drug research findings and conclusion.